196 related articles for article (PubMed ID: 12086766)
1. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors.
Adam A; Cugno M; Molinaro G; Perez M; Lepage Y; Agostoni A
Lancet; 2002 Jun; 359(9323):2088-9. PubMed ID: 12086766
[TBL] [Abstract][Full Text] [Related]
2. Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema.
Bas M; Hoffmann TK; Tiemann B; Dao VT; Bantis C; Balz V; Schultz-Coulon HJ; Stark T; Schuler P; Greve J; Ivens K; Bier H; Kojda G
Br J Clin Pharmacol; 2010 Feb; 69(2):179-86. PubMed ID: 20233181
[TBL] [Abstract][Full Text] [Related]
3. [ACE inhibitor-induced angioedema: remarkable new perspectives for intensive care/emergency medicine].
Wernze H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):637-41. PubMed ID: 9825047
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema.
Sabroe RA; Black AK
Br J Dermatol; 1997 Feb; 136(2):153-8. PubMed ID: 9068723
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitor and visceral angio-oedema.
Chuah HS; O'Donnell D
Emerg Med Australas; 2012 Apr; 24(2):207-8. PubMed ID: 22487673
[TBL] [Abstract][Full Text] [Related]
6. Plasma bradykinin in angio-oedema.
Nussberger J; Cugno M; Amstutz C; Cicardi M; Pellacani A; Agostoni A
Lancet; 1998 Jun; 351(9117):1693-7. PubMed ID: 9734886
[TBL] [Abstract][Full Text] [Related]
7. A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema.
Cilia La Corte AL; Carter AM; Rice GI; Duan QL; Rouleau GA; Adam A; Grant PJ; Hooper NM
Hum Mutat; 2011 Nov; 32(11):1326-31. PubMed ID: 21898657
[TBL] [Abstract][Full Text] [Related]
8. Life-threatening angio-oedema and death associated with the ACE inhibitor enalapril.
Cupido C; Rayner B
S Afr Med J; 2007 Apr; 97(4):244-5. PubMed ID: 17446944
[No Abstract] [Full Text] [Related]
9. Iatrogenic angioedema associated with ACEi, sitagliptin, and deficiency of 3 enzymes catabolizing bradykinin.
Beaudouin E; Defendi F; Picaud J; Drouet C; Ponard D; Moneret-Vautrin DA
Eur Ann Allergy Clin Immunol; 2014 May; 46(3):119-22. PubMed ID: 24853572
[TBL] [Abstract][Full Text] [Related]
10. Life-threatening ACE inhibitor-induced angio-oedema successfully treated with icatibant: a bradykinin receptor antagonist.
Ostenfeld S; Bygum A; Rasmussen ER
BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26498671
[TBL] [Abstract][Full Text] [Related]
11. [Angioedema associated with ACE inhibitors].
Nielsen EW; Stenberg PA; Einarsen E; Johansen HT; Mollnes TE
Tidsskr Nor Laegeforen; 1994 Mar; 114(7):804-6. PubMed ID: 8009499
[TBL] [Abstract][Full Text] [Related]
12. [Angio-oedema and medication that interferes with the renin-angiotensin-aldosterone system--a systematic review].
Suhrs HE; Ibsen H
Ugeskr Laeger; 2012 Mar; 174(11):724-9. PubMed ID: 22409895
[TBL] [Abstract][Full Text] [Related]
13. Life-threatening angio-oedema after the first dose of an ACE inhibitor-not an anaphylactic reaction.
Krogh Nielsen T; Bygum A; Rye Rasmussen E
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27229746
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin-receptor antagonist icatibant: possible treatment for ACE inhibitor-related angio-oedema.
Manders K; van Deuren M; Hoedemaekers C; Simon A
Neth J Med; 2012 Oct; 70(8):386-7. PubMed ID: 23065991
[No Abstract] [Full Text] [Related]
15. [C1-esterase inhibitor in ACE inhibitor-induced severe angioedema of the tongue].
Steinbach O; Schweder R; Freitag B
Anaesthesiol Reanim; 2001; 26(5):133-7. PubMed ID: 11712230
[TBL] [Abstract][Full Text] [Related]
16. Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.
Hedner T; Samuelsson O; Lunde H; Lindholm L; Andrén L; Wiholm BE
BMJ; 1992 Apr; 304(6832):941-6. PubMed ID: 1581715
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency and severity of angio-oedema related to long-term therapy with angiotensin-converting enzyme inhibitor in two patients.
Kozel MM; Mekkes JR; Bos JD
Clin Exp Dermatol; 1995 Jan; 20(1):60-1. PubMed ID: 7671401
[TBL] [Abstract][Full Text] [Related]
18. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor.
Sigler C; Annis K; Cooper K; Haber H; Van deCarr S
Arch Dermatol; 1997 Aug; 133(8):972-5. PubMed ID: 9267242
[TBL] [Abstract][Full Text] [Related]
19. [Life-threatening postoperative angioedema following treatment with an angiotensin converting enzyme inhibitor].
Maier C
Anaesthesist; 1995 Dec; 44(12):875-9. PubMed ID: 8594963
[TBL] [Abstract][Full Text] [Related]
20. Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke.
Hurford R; Rezvani S; Kreimei M; Herbert A; Vail A; Parry-Jones AR; Douglass C; Molloy J; Alachkar H; Tyrrell PJ; Smith CJ
J Neurol Neurosurg Psychiatry; 2015 May; 86(5):520-3. PubMed ID: 25016564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
